Literature DB >> 20130048

Bimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusion.

Doina Atanasiu1, J Charles Whitbeck, Manuel Ponce de Leon, Huan Lou, Brian P Hannah, Gary H Cohen, Roselyn J Eisenberg.   

Abstract

Herpes simplex virus (HSV) entry into cells requires four membrane glycoproteins: gD is the receptor binding protein, and gB and gH/gL constitute the core fusion machinery. Crystal structures of gD and its receptors have provided a basis for understanding the initial triggering steps, but how the core fusion proteins function remains unknown. The gB crystal structure shows that it is a class III fusion protein, yet unlike other class members, gB itself does not cause fusion. Bimolecular complementation (BiMC) studies have shown that gD-receptor binding triggers an interaction between gB and gH/gL and concurrently triggers fusion. Left unanswered was whether BiMC led to fusion or was a by-product of it. We used gB monoclonal antibodies (MAbs) to block different aspects of these events. Non-virus-neutralizing MAbs to gB failed to block BiMC or fusion. In contrast, gB MAbs that neutralize virus blocked fusion. These MAbs map to three functional regions (FR) of gB. MAbs to FR1, which contains the fusion loops, and FR2 blocked both BiMC and fusion. In contrast, MAbs to FR3, a region involved in receptor binding, blocked fusion but not BiMC. Thus, FR3 MAbs separate the BiMC interaction from fusion, suggesting that BiMC occurs prior to fusion. When substituted for wild-type (wt) gB, fusion loop mutants blocked fusion and BiMC, suggesting that loop insertion precedes BiMC. Thus, we postulate that each of the gB FRs are involved in different aspects of the path leading to fusion. Upon triggering by gD, gB fusion loops are inserted into target lipid membranes. gB then interacts with gH/gL, and this interaction is eventually followed by fusion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130048      PMCID: PMC2849501          DOI: 10.1128/JVI.02687-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

2.  Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: scope and mechanism.

Authors:  Thomas J Magliery; Christopher G M Wilson; Weilan Pan; Dennis Mishler; Indraneel Ghosh; Andrew D Hamilton; Lynne Regan
Journal:  J Am Chem Soc       Date:  2005-01-12       Impact factor: 15.419

3.  Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.

Authors:  Claude Krummenacher; Vinit M Supekar; J Charles Whitbeck; Eric Lazear; Sarah A Connolly; Roselyn J Eisenberg; Gary H Cohen; Don C Wiley; Andrea Carfí
Journal:  EMBO J       Date:  2005-11-17       Impact factor: 11.598

4.  Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Huan Lou; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G.

Authors:  Stéphane Roche; Stéphane Bressanelli; Félix A Rey; Yves Gaudin
Journal:  Science       Date:  2006-07-14       Impact factor: 47.728

6.  Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.

Authors:  Tina M Cairns; Marie S Shaner; Yi Zuo; Manuel Ponce-de-Leon; Isabelle Baribaud; Roselyn J Eisenberg; Gary H Cohen; J Charles Whitbeck
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Use of herpes simplex virus and pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion.

Authors:  Anna Zago; Cheryl R Jogger; Patricia G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

8.  Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.

Authors:  K Okuma; M Nakamura; S Nakano; Y Niho; Y Matsuura
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

9.  Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex.

Authors:  T Peng; M Ponce de Leon; M J Novotny; H Jiang; J D Lambris; G Dubin; P G Spear; G H Cohen; R J Eisenberg
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Examination of the kinetics of herpes simplex virus glycoprotein D binding to the herpesvirus entry mediator, using surface plasmon resonance.

Authors:  S H Willis; A H Rux; C Peng; J C Whitbeck; A V Nicola; H Lou; W Hou; L Salvador; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  81 in total

1.  Structure-based functional analyses of domains II and III of pseudorabies virus glycoprotein H.

Authors:  Sebastian W Böhm; Elisa Eckroth; Marija Backovic; Barbara G Klupp; Felix A Rey; Thomas C Mettenleiter; Walter Fuchs
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Autographa californica multiple nucleopolyhedrovirus GP64 protein: roles of histidine residues in triggering membrane fusion and fusion pore expansion.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

Review 3.  Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.

Authors:  Lindsey M Hutt-Fletcher; Liudmila S Chesnokova
Journal:  Virulence       Date:  2010 Sep-Oct       Impact factor: 5.882

4.  Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.

Authors:  Martin P Däumer; Beate Schneider; Doris M Giesen; Sheriff Aziz; Rolf Kaiser; Bernd Kupfer; Karl E Schneweis; Jens Schneider-Mergener; Ulrich Reineke; Bertfried Matz; Anna M Eis-Hübinger
Journal:  Med Microbiol Immunol       Date:  2010-10-08       Impact factor: 3.402

5.  Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB.

Authors:  Doina Atanasiu; Wan Ting Saw; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

6.  Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.

Authors:  Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

7.  Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle.

Authors:  Hiroko Oyaizu; Huamin Tang; Megumi Ota; Nobuyuki Takenaka; Keiichi Ozono; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

8.  Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins.

Authors:  Doina Atanasiu; Wan Ting Saw; John R Gallagher; Brian P Hannah; Zene Matsuda; J Charles Whitbeck; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

9.  Regulation of Herpes Simplex Virus Glycoprotein-Induced Cascade of Events Governing Cell-Cell Fusion.

Authors:  Doina Atanasiu; Wan Ting Saw; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  The Neutralizing Linear Epitope of Human Herpesvirus 6A Glycoprotein B Does Not Affect Virus Infectivity.

Authors:  Aika Wakata; Satoshi Kanemoto; Huamin Tang; Akiko Kawabata; Mitsuhiro Nishimura; Chyntia Jasirwan; Nora Fahmy Mahmoud; Yasuko Mori
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.